Can a Child Outgrow Epilepsy? What the Science Says

Many children with epilepsy do eventually stop having seizures, and the numbers are more encouraging than most parents expect. Long-term studies consistently find that roughly 60 to 65 percent of children diagnosed with epilepsy reach a point where seizures have been gone for years and medication is no longer needed. But “outgrowing” epilepsy is not one story; it depends heavily on what type of epilepsy a child has, what is causing it, and how their brain responds during key developmental windows.

What the Numbers Actually Show

The broadest and most frequently cited figure comes from population-based follow-up studies. In a Finnish cohort that tracked 516 children for at least a decade, 63 percent achieved complete remission, meaning they were seizure-free and off all medication. Of those who reached remission, only 23 relapsed.¹ Other long-term data lines up closely: about two out of three patients with new-onset epilepsy eventually enter a five-year period free of seizures.² And population-based reviews confirm that remission from childhood-onset epilepsy occurs in at least half of all children, with some estimates reaching 60 percent when counting those who are off medication and in full remission.

Those numbers are averages across all childhood epilepsies, though. Some syndromes almost always resolve on their own. Others rarely do. The specific diagnosis a child carries matters far more than the label “epilepsy” alone.

What Doctors Mean by “Resolved”

Parents often ask whether their child’s epilepsy is “cured.” Neurologists tend to avoid that word. The International League Against Epilepsy, the professional body that sets diagnostic standards, introduced the term “resolved” to describe epilepsy that is no longer active. Under their practical definition, epilepsy is considered resolved when a person has remained seizure-free for at least ten years and has been off all anti-seizure medication for at least the last five of those years.³ The same definition applies to children who had an age-dependent epilepsy syndrome and have now passed the age at which that syndrome is expected to occur.

The choice of “resolved” rather than “cured” is deliberate. It acknowledges that the seizures stopped and the person no longer meets the criteria for active epilepsy, while leaving open the small possibility that seizures could someday return. For most families, “resolved” is functionally the same as outgrown, but the medical community prefers language that reflects what the data actually show: a very low but nonzero residual risk.

Syndromes That Children Typically Outgrow

Certain childhood epilepsy syndromes are so reliably self-limited that neurologists now call them exactly that. The two most common ones parents encounter are self-limited epilepsy with centrotemporal spikes (formerly called benign rolandic epilepsy) and childhood absence epilepsy.

Self-limited epilepsy with centrotemporal spikes usually starts between ages 3 and 13, producing brief seizures that involve twitching around the mouth and face, often during sleep. It almost universally resolves by mid-adolescence. Both typical and atypical variants follow a similar timeline of resolution, though they may begin at different ages.⁴ Many children with this syndrome need little or no medication, and parents are often reassured early on that the seizures will stop as the brain matures.

Childhood absence epilepsy, which produces brief staring spells dozens of times a day, also carries a favorable long-term outlook. In one long-term follow-up study, about 65 percent of patients were in full remission, and another 17 percent were off medication though still experiencing occasional seizures.⁵ A separate study found an even higher remission rate of about 79 percent.⁶ However, the earlier study also flagged an important wrinkle: roughly 15 percent of children with childhood absence epilepsy progressed to juvenile myoclonic epilepsy, a different syndrome that behaves quite differently.⁵

Syndromes That Tend to Stick Around

Juvenile myoclonic epilepsy is the classic example of a childhood-onset epilepsy that does not resolve. It typically appears in the early teen years and produces sudden jerking movements, often in the morning, along with generalized tonic-clonic seizures. Most patients respond well to medication and can live normal lives, but JME is widely considered a chronic condition that requires lifelong treatment.⁷ The conventional teaching in neurology is that both juvenile myoclonic epilepsy and juvenile absence epilepsy carry high relapse rates when medication is withdrawn.⁸

This distinction creates a sharp line in how neurologists counsel families. If a child has rolandic epilepsy, the conversation centers on patience and likely resolution. If a teenager is diagnosed with JME, the conversation shifts to long-term medication management. The same word, “epilepsy,” describes both situations, which is one reason the diagnosis alone can feel confusing to families.

Why Some Children Outgrow It and Others Do Not

The developing brain is the central character in this story. During childhood, the cortex has an excess of both excitatory and inhibitory connections. As the brain matures, unnecessary axonal branches and their synapses are pruned away.⁹ In self-limited epilepsies, the brain’s abnormal electrical activity seems tied to a temporary developmental state. Once the relevant circuits finish maturing and the surplus connections are eliminated, the seizures stop. The epilepsy was essentially a byproduct of a brain that was still under construction.

Puberty appears to be one of the critical junctures. Several epilepsy types, including rolandic epilepsy, commonly remit around the time puberty begins, while other syndromes like JME and photosensitive epilepsy may emerge during that same hormonal transition.¹⁰ Reproductive hormones influence how excitable neurons are, and these effects are complex enough that the same hormonal changes that help one type of epilepsy resolve can trigger another.¹¹

When epilepsy does not resolve, the cause is often structural. A child whose epilepsy stems from a brain malformation, a scar from an earlier injury, or a genetic condition affecting ion channels throughout the brain is far less likely to outgrow seizures, because the underlying problem does not change with maturation.

Predicting Which Children Will Reach Remission

Neurologists have identified several factors that help predict whether a child’s epilepsy will resolve. The strongest predictors of a good outcome include onset before about age 12, absence of other neurological problems, normal intelligence, and a low number of seizures before treatment begins.¹² Children with symptomatic epilepsy, meaning seizures caused by an identifiable brain abnormality, do worse than those whose epilepsy has no visible structural cause.

Among children who appear medically intractable early on (seizures not controlled within the first two years), the single strongest predictor of whether that intractability will persist is an abnormality on brain imaging. A neuroimaging abnormality carried a seven-fold increase in the risk of enduring intractability.¹³ An abnormal neurological exam at diagnosis also raised the risk, though less dramatically. These findings give clinicians a way to identify, fairly early, which children may need more aggressive intervention and which may still be on a path toward remission.

When Medication Stops

Even when a child has been seizure-free for years, tapering off medication is a nerve-wracking decision. The recurrence rate after stopping anti-seizure drugs varies considerably across studies, reported anywhere from 16 to 56 percent depending on the population and how long patients were followed.¹⁴ In one study that followed children after a seizure-free period of at least two years and a normal EEG, roughly 75 percent remained seizure-free after medication was withdrawn.¹⁵

The timing of relapse is fairly consistent across studies. If seizures are going to come back, they usually do so within the first year or two. In one study, over 60 percent of recurrences happened within the first six months after stopping medication, with another quarter occurring between six and twelve months.¹⁴ After two years off medication with no seizures, the risk drops dramatically. This pattern is why neurologists typically monitor most closely during that first year or two after a medication taper.

A very long-term population-based study tracking patients an average of 32 years after drug discontinuation found that about a third ultimately relapsed.¹⁶ That number is higher than the short-term studies suggest, indicating that a small trickle of late relapses continues over decades. Still, two-thirds remained seizure-free permanently.

The Role of EEG in Deciding to Stop Treatment

Brain wave recordings are one of the tools neurologists use when deciding whether a child is ready to taper medication. Among pediatric neurologists in the United States, about half say an abnormal EEG would lead them to avoid weaning a child off medication, while about 46 percent say they would weigh additional factors like family discussions before deciding.¹⁷ Practice varies quite a bit. There is no universal rule that says a child must have a perfectly clean EEG before stopping treatment, but an abnormal recording raises a red flag.

In one small study of children with idiopathic generalized epilepsy who had a repeat EEG within six months after stopping medication, only a small fraction showed abnormal findings, and none of those patients had actually experienced a clinical seizure relapse at over a year of follow-up.¹⁸ That raises questions about how useful routine repeat EEGs are in lower-risk patients, though the data is still too limited to draw broad conclusions.

What Happens to Cognition After Epilepsy Resolves

Here is something that surprises many families: even after epilepsy fully resolves, there can be a subtle cognitive footprint. A large Israeli cohort study compared young adults whose childhood epilepsy had resolved with peers who never had epilepsy. Those in the resolved epilepsy group were about 25 to 44 percent more likely to score in the low cognitive range on standardized testing, depending on the model used.¹⁹ The absolute numbers are reassuring for most families, as the vast majority of young adults with resolved epilepsy scored within the normal range. But the finding suggests that childhood epilepsy leaves a trace on brain development even when seizures stop entirely.

The earlier childhood absence epilepsy data also hints at this: about a quarter of children whose absence epilepsy resolved still needed psychological or academic support afterward.⁶ Whether the cognitive effects come from the seizures themselves, from anti-seizure medications taken during formative years, or from whatever underlying brain difference made seizures possible in the first place is still debated. Probably all three contribute to different degrees in different children.

The Ketogenic Diet and Long-Term Seizure Outcomes

For children with drug-resistant epilepsy, the ketogenic diet is sometimes used as a treatment when medications fail. An interesting question is whether benefits persist after the diet is stopped. In an Argentinean multicenter study, 20 patients who had become seizure-free on the diet eventually discontinued it. Seizures returned in five of them, a 25 percent relapse rate.²⁰ A separate multi-center case review found that about 63 percent of patients maintained their response after stopping the diet, with roughly a third sustaining that improvement without any further anti-seizure treatments.²¹

For certain specific syndromes, the ketogenic diet seems to do particularly well. In myoclonic-astatic epilepsy (Doose syndrome), early introduction of the diet was associated with long-term remission and better cognitive outcomes.²² These findings are encouraging, but they come from relatively small studies of children who already had hard-to-treat epilepsy. The diet is not a routine path to “outgrowing” epilepsy in the way that normal brain maturation is for self-limited syndromes.

Disparities in Who Reaches Remission

Not every child has the same chance of reaching remission, and the reasons are not purely biological. A study examining pediatric epilepsy outcomes by race and ethnicity found that while clinical features like the number of hospitalizations and brain scans were similar across groups, Hispanic patients had significantly more emergency department visits and higher epilepsy-related costs compared to non-Hispanic White patients.²³ These disparities in how care is accessed and delivered raise the possibility that differences in remission rates across demographic groups are not simply about the biology of epilepsy but also about access to timely, consistent treatment.

The economics of childhood epilepsy also shift dramatically depending on whether seizures come under control. An Italian analysis found that annual direct medical costs for a child in remission were roughly a quarter of the costs for a child with drug-resistant epilepsy.²⁴ Getting seizures under control, whether through medication, diet, or surgery, produces cost savings that compound over years of childhood and adolescence. This economic dimension is rarely discussed with families, but it underscores why early effective treatment is not just a clinical priority but a financial one for healthcare systems.

How Puberty Reshuffles the Deck

Puberty is a turning point for childhood epilepsy in both directions. The hormonal surge that accompanies adolescence helps shut down certain epilepsy circuits, which is why self-limited epilepsy with centrotemporal spikes and some forms of absence epilepsy fade in the early teenage years. But the same developmental window can activate new seizure types. Juvenile myoclonic epilepsy, photosensitive epilepsy, and catamenial epilepsy (seizures linked to the menstrual cycle) all commonly emerge during or just after puberty.¹⁰

The relationship between sex hormones and seizures is not straightforward. Estrogen generally makes neurons more excitable, while progesterone tends to have a calming effect. But these hormones interact with seizure networks through multiple pathways, and the net result depends on timing, concentration, and the specific type of epilepsy involved.¹¹ For girls in particular, the transition through puberty sometimes reveals whether a childhood epilepsy will truly resolve or evolve into a different seizure disorder. Neurologists generally want to see stability through at least the early adolescent years before declaring victory.

For families watching a child move through this transition, the practical message is that puberty is a period of change for epilepsy, not necessarily of permanent improvement. A child who seemed to be outgrowing seizures may need reassessment if new seizure types appear, and a child whose seizures persisted through early adolescence is not necessarily destined for lifelong epilepsy if their syndrome is not one of the chronic types.